Status:
NOT_YET_RECRUITING
Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
Lead Sponsor:
Power Life Sciences Inc.
Conditions:
Recurrent Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
Clinical studies, with a dedicated focus on recurrent prostate cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition. These trials serve as ess...
Eligibility Criteria
Inclusion
- Patient is at least 18 years of age
- Diagnosis of recurrent prostate cancer
- Ability to understand and the willingness to sign a written informed consent document
Exclusion
- Enrolled in another research study
- Patients with psychiatric illness/social situations that would limit compliance with study requirements
- Inability to provide written informed consent
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06070272
Start Date
October 1 2024
End Date
October 1 2026
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Power Life Sciences
San Francisco, California, United States, 94107